Effect of vitamin K in bone metabolism and vascular calcification: A review of mechanisms of action and evidences

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 18, 2017, Pages 3959-3970

  Villa, Julia Khéde Dourado ^a   Diaz, Marisa Alves Nogueira ^a   Pizziolo, Virgínia Ramos ^a   Martino, Hércia Stampini Duarte ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

cardiovascular disease; Menaquinone; osteoporosis; postmenopause

Indexed keywords

BIOMINERALIZATION; BLOOD VESSELS; CARBOXYLATION; CELL DEATH; CELLS; DISEASES; HEALTH RISKS; KETONES; MUSCLE; OSTEOBLASTS; PHOSPHATASES; PROTEINS;

CARDIO-VASCULAR DISEASE; GROWTH ARREST SPECIFIC GENES; INSULIN-LIKE GROWTH FACTOR-1; MENAQUINONE; OSTEOBLAST DIFFERENTIATION; OSTEOPOROSIS; POSTMENOPAUSE; VASCULAR SMOOTH MUSCLE CELLS;

BONE;

FARNOQUINONE; OSTEOCALCIN; VITAMIN K GROUP;

BLOOD VESSEL CALCIFICATION; BONE; CELL TRANSDIFFERENTIATION; DRUG EFFECTS; HUMAN; METABOLISM; OSTEOPOROSIS; PHYSIOLOGY;

BONE AND BONES; CELL TRANSDIFFERENTIATION; HUMANS; OSTEOCALCIN; OSTEOPOROSIS; VASCULAR CALCIFICATION; VITAMIN K; VITAMIN K 2;

EID: 85029715819     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2016.1211616     Document Type: Article

References (99)

1. Abedin, M., Tintut, Y., and Demer, L., (2004). Vascular calcifications: Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 24:1161–1170.
2. Al Rajabi, A., Booth, S., Peterson, J., Choi, S., Suttie, J., Shea, M., Miao, B., Grusak, M., and Fu, X., (2012). Deuterium-Labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats. J. Nutr. 142:841–845.
3. Beulens, J., Bots, M., Atsma, F., Bartelink, M-L., Prokop, M., Geleijnse, J., Witteman, J., Grobbee, D., and Schouw, Y., (2009). High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 203:489–493.
4. Binkley, N., Harke, J., Krueger, D., Engelke, J., Vallarta-Ast, N., Checovich, M., Chappell, R., and Suttie, J., (2009). Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res. 24:983–991.
5. Brandenburg, V., Schurgers, L., Kaesler, N., Püsche K., Gorp, R., Leftheriotis, G., Reinartz, S., Koos, R., and Krüger, T., (2015). Prevention of vasculopathy by vitamin K supplementation: Can we turn fiction into fact? Atherosclerosis. 240:10–16.
6. Caluwé, R., Vandecasteele, S., Van Vlem, B., Vermeer, C., and De Vriese, A., (2014). Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrol Dial Transplant. 29:1385–1390.
7. Cancela, M., Conceição, N., and Laizé, V., (2012). Gla-Rich Protein, a new player in tissue calcification? Adv Nutr. 3:174–181.
8. Chatrou, M., Winckers, K., Hackeng, T., Reutelingsperger, C., and Schurgers, L., (2012). Vascular calcification: The price to pay for anticoagulation therapy with vitamin K-antagonists. Blood Rev. 26:155–166.
9. Chenu, C., Serre, C., Raynal, C., Burt-Pichat, B., and Delmas, P., (1998). Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone. 22:295–299.
10. Cheung, A., Tile, L., Lee, Y., Tomlinson, G., Hawker G., Scher, J., Hu, H., Vieth, R., Thompson, L., Jamal, S., and Josse, R., (2008). Vitamin K supplementation in postmenopausal women with osteopenia (ECKO Trial): A randomized controlled trial. PLoS Med. 5:1461–1472.
11. Cockayne, S., Adamson, J., Lanham-New, S., Shearer, M., Gilbody, S., and Torgerson, D., (2006). Vitamin K and the prevention of fractures: Systematic review and meta-analysis of randomized controlled trials. Arch. Intern. Med. 166:1256–1261.
12. Confavreux, C., Szulc, P., Casey, R., Boutroy, S., Varennes, A., Vilayphiou, N., Goudable, J., and Chapurlat, R., (2013). Higher serum osteocalcin is associated with lower abdominal aortic calcification progression and longer 10-year survival in elderly men of the MINOS cohort. J. Clin. Endocrinol Metab. 98:1084–1092.
13. Cranenburg, E., Schurgers, L., and Vermeer, C., (2007). Vitamin K: The coagulation vitamin that became omnipotent. Thromb Haemost. 98:120–125.
14. Dalmeijer, G., van der Schouw, Y., Magdeleyns, E., Ahmed, N., Vermeer, C., and Beulens, J., (2012). The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis. 225:397–402.
15. Dalmeijer, G., van der Schouw, Y., Magdeleyns, E., Vermeer, C., Verschuren, W., Boer, J., and Beulens, J., (2013). Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care. 36:3766–3771.
16. Doherty, T., Asotra, K., Fitzpatrick, L., Qiao, J., Wilkin, D., Detrano, R., Dunstan, C., Shah, P., and Rajavashisth, T., (2003). Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads. Proc. Natl. Acad. Sci. U S A. 100:11201–1126.
17. Duer, M., Friscić, T., Proudfoot, D., Reid, D., Schoppet, M., Shanahan, C., Skepper, J., and Wise, E., (2008). Mineral surface in calcified plaque is like that of bone further evidence for regulated mineralization. Arterioscler Thromb Vasc Biol. 28:2030–2034.
18. Emaus, N., Gjesdal, C., Almås, B., Christensen, M., Grimsgaard, A., Berntsen, G., Salomonsen, L., and Fønnebø, V., (2010). Vitamin K2 supplementation does not influence bone loss in early menopausal women: A randomised double-blind placebo-controlled trial. Osteoporos Int. 21:1731–1740.
19. Fang, Y., Hu, C., Tao, X., Wan, Y., and Tao, F., (2012). Effect of vitamin K on bone mineral density: A meta-analysis of randomized controlled trials. J. Bone Miner Metab. 30:60–68.
20. Fusaro, M., Noale, M., Viola, V., Galli, F., Tripepi, G., Vajente, N., Plebani, M., Zaninotto, M., Guglielmi, G., Miotto, D., Dalle Carbonare, L., D'Angelo, A., Naso, A., Grimaldi, C., Miozzo, D., Giannini, S., Gallieni, M., and Vitamin K Italian (VIKI) Dialysis Study Investigators. (2012). Vitamin K, vertebral fractures, vascular calcifications, and mortality: Vitamin K Italian (VIKI) dialysis study. J Bone Miner Res. 27:2271–2278.
21. Gallieni, M., and Fusaro, M., (2014). Vitamin K and cardiovascular calcification in CKD: Is patient supplementation on the horizon? Kidney Int. 86:232–234.
22. Gast, G., de Roos, N., Sluijs, I., Bots, M., Beulens, J., Geleijnse, J., Witteman, J., Grobbee, D., Peeters, P., and van der Schouw, Y., (2009). A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 19:504–510.
23. Geleijnse, J., Vermeer, C., Grobbee, D., Schurgers, L., Knapen, M., van der Meer, I., Hofman, A., and Witteman, J., (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The rotterdam study. J. Nutr. 134:3100–3105.
24. Ghiron, L., Thompson, J., Holloway, L., Hintz, R., Butterfield, G., Hoffman, A., and Marcus, R., (1995). Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J. Bone Miner Res. 10:1844–1852.
25. Glowacki, J., and Lian, J., (1987). Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differ. 21:247–254.
26. Gundberg, C., Lian, J., and Booth, S., (2012). Vitamin K-dependent carboxylation of osteocalcin: Friend or foe? Adv. Nutr. 3:149–157.
27. Hamidi, M., Gajic-Veljanoski, O., and Cheung, A., (2013). Vitamin K and bone health. J. Clin. Densitom. 16:409–413.
28. Hara, K., Kobayashi, M., and Akiyama, Y., (2002). Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone. 31:575–581.
29. Hauschka, P., Lian, J., Cole, D., and Gundberg, C., (1989). Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol. Rev. 69:990–1047.
30. Hirao, M., Hashimoto, J., Ando, W., Ono, T., and Yoshikawa, H., (2008). Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J. Bone Miner Metab. 26:260–264.
31. Holden, R., Morton, A., Garland, J., Pavlov, A., Day, A., and Booth, S., (2010). Vitamins K and D status in stages 3–5 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5:590–597.
32. Huang, Z., Wan, S., Lu, Y., Ning, L., Liu, C., and Fan, S., (2014). Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: A meta-analysis of randomized controlled trials. Osteoporos Int. 26:1175–1186.
33. Ichikawa, T., Horie-Inoue, K., Ikeda, K., Blumberg, B., and Inoue, S., (2007). Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J. Mol. Endocrinol. 39:239–247.
34. Inoue, T., Fujita, T., Kishimoto, H., Makino, T., Nakamura, T., Nakamura, T., Sato, T., and Yamazaki, K., (2009). Randomized controlled study on the prevention of osteoporotic fractures (OF study): A phase IV clinical study of 15-mg menatetrenone capsules. J. Bone Miner Metab. 27:66–75.
35. Iribarren, C., Sidney, S., Sternfeld, B., and Browner, W., (2000). Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA. 283:2810–2815.
36. Ishida, Y., and Kawai, S., (2004). Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The yamaguchi osteoporosis prevention study. Am. J. Med. 117:549–555.
37. Iwamoto, I., Kosha, S., Noguchi, S., Murakami, M., Fujino, T., Douchi, T., and Nagata, Y., (1999). A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen–progestin therapy. Maturitas. 31:161–164.
38. Iwamoto, J., Takeda, T., and Ichimura, S., (2000). Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J. Orthop Sci. 5:546–551.
39. Iwamoto, J., Takeda, T., and Sato, Y., (2006). Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis. Nutr Rev. 64:509–517.
40. Iwamoto, J., Matsumoto, H., Takeda, T., Sato, Y., Liu, X., and Yeh, J., (2008). Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats. Calcif Tissue Int. 83:121–128.
41. Je, S., Joo, N., Choi, B., Kim, K., Kim, B., Park, S., Cho, D., Kim, K., and Lee, D., (2011). Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old. J. Korean Med. Sci. 26:1093–1098.
42. Jie, K., Bots, M., Vermeer, C., Witteman, J., and Grobbee, D., (1995). Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: A population-based study. Atherosclerosis. 116:117–123.
43. Kaesler, N., Magdeleyns, E., Herfs, M., Schettgen, T., Brandenburg, V., Fliser, D., Vermeer, C., Floege, J., Schlieper, G., and Krüger, T., (2014). Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int. 86:286–293.
44. Kameda, T., Miyazawa, K., Mori, Y., Yuasa, T., Shiokawa, M., Nakamaru, Y., Mano, H., Hakeda, Y., Kameda, A., and Kumegawa, M., (1996). Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem. Biophys. Res. Commun. 220:515–519.
45. Kanellakis, S., Moschonis, G., Tenta, R., Schaafsma, A., van den Heuvel, E., Papaioannou, N., Lyritis, G., and Manios, Y., (2012). Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (Vitamin K1) or Menaquinone-7 (Vitamin K2): The postmenopausal health study. Calcif Tissue Int. 90:251–262.
46. Kasukawa, Y., Miyakoshi, N., Ebina, T., Aizawa, T., Hongo, M., Nozaka, K., Ishikawa, Y., Saito, H., Chida, S., and Shimada, Y., (2014). Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis. J. Bone Miner Metab. 32:290–297.
47. Koitaya, N., Ezaki, J., Nishimuta, M., Yamauchi, J., Hashizume, E., Morishita, K., Miyachi, M., Sasaki, S., and Ishimi, Y., (2009). Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. J. Nutr Sci. Vitaminol (Tokyo). 55:15–21.
48. Koitaya, N., Sekiguchi, M., Tousen, Y., Nishide, Y., Morita, A., Yamauchi, J., Gando, Y., Miyachi, M., Aoki, M., Komatsu, M., Watanabe, F., Morishita, K., and Ishimi, Y., (2014). Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women. J. Bone Miner Metab. 32:142–150.
49. Koos, R., Krueger, T., Westenfeld, R., Kühl, H., Brandenburg, V., Mahnken, A., Stanzel, S., Vermeer, C., Cranenburg, E., Floege, J., Kelm, M., and Schurgers, L., (2009). Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost. 101:706–713.
50. Koshihara, Y., Hoshi, K., Okawara, R., Ishibashi, H., and Yamamoto, S., (2003). Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J. Endocrinol. 176:339–348.
51. Kurnatowska, I., Grzelak, P., Masajtis-Zagajewska, A., Kaczmarska, M., Stefańczyk, L., Vermeer, C., Maresz, K., and Nowicki, M., (2015). Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in non-dialyzed patients with chronic kidney disease stage 3–5. Pol Arch. Med. Wewn. 125:631–640.
52. Lampropoulos, C., Papaioannou, I., and D'Cruz, D., (2012). Osteoporosis—A risk factor for cardiovascular disease?. Nat. Rev. Rheumatol. 8:587–598.
53. Luo, G., Ducy, P., McKee, M., Pinero, G., Loyer, E., Behringer, R., and Karsenty, G., (1997). Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386:78–81.
54. Maas, A., van der Schouw, Y., Beijerinck, D., Deurenberg, J., Mali, W., Grobbee, D., and van der Graaf, Y., (2007). Vitamin K intake and calcifications in breast arteries. Maturitas. 56:273–279.
55. Mayer, O., Seidlerová, J., Bruthans, J., Filipovský, J., Timoracká, K., Vaněk, J., Cerná, L., Wohlfahrt, P., Cífková, R., Theuwissen, E., and Vermeer, C., (2014). Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis. 235:162–168.
56. McCabe, K., Booth, S., Fu, X., Shobeiri, N., Pang, J., Adams, M., and Holden, R., (2013). Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 83:835–844.
57. Niemeier, A., Niedzielska, D., Secer, R., Schilling, A., Merkel, M., Enrich, C., Rensen, P., Heeren, J., (2008). Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone. 43:230–237.
58. Onodera, K., Takahashi, A., Wakabayashi, H., Kamei, J., and Sakurada, S., (2003). Effects of menatetrenone on the bone and serum levels of vitamin K2 (menaquinone derivatives) in osteopenia induced by phenytoin in growing rats. Nutrition. 19:446–450.
59. Owen, T., Aronow, M., Shalhoub, V., Barone, L., Wilming, L., Tassinari, M., Kennedy, M., Pockwinse, S., Lian, J., and Stein, G., (1990). Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell Physiol. 143:420–430.
60. Ozuru, R., Sugimoto, T., Yamaguchi, T., and Chihara, K., (2002). Time dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J. 49:363–370.
61. Price, P., Faus, S., and Williamson, M., (1998). Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol. 18:1400–1407.
62. Proudfoot, D., Skepper, J., Hegyi, L., Bennett, M., Shanahan, C., and Weissberg, P., (2000). Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 87:1055–1062.
63. Rajamannan, N., Subramaniam, M., Rickard, D., Stock, S., Donovan, J., Springett, M., Orszulak, T., Fullerton, D., Tajik, A., Bonow, R., and Spelsberg, T., (2003). Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 107:2181–2185.
64. Razzaque, M., (2011). Osteocalcin: A pivotal mediator or an innocent bystander in energy metabolism? Nephrol Dial Transplant. 26:42–45.
65. Riggs, B., and Parfitt, A., (2005). Drugs used to treat osteoporosis: The critical need for a uniform nomenclature based on their action on bone remodeling. J. Bone Miner Res. 20:177–184.
66. Roijers, R., Debernardi, N., Cleutjens, J., Schurgers, L., Mutsaers, P., and van der Vusse, G., (2011). Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. Am. J. Pathol. 178:2879–2887.
67. Sato, T., Schurgers, L., and Uenishi, K., (2012). Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 11:93.
68. Schinke, T., Mckee, M., and Karsenty, G., (1999). Extracellular matrix calcification: Where is the action? Nat. Genet. 21:150–151.
69. Schlieper, G., Westenfeld, R., Krüger, T., Cranenburg, E., Magdeleyns, E., Brandenburg, V., Djuric, Z., Damjanovic, T., Ketteler, M., Vermeer, C., Dimkovic, N., Floege, J., and Schurgers, L., (2011). Circulating nonphosphorylated carboxylated Matrix Gla Protein predicts survival in ESRD. J. Am. Soc. Nephrol. 22:387–395.
70. Schurgers, L., and Vermeer, C., (2000). Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 30:298–307.
71. Schurgers, L., and Vermeer, C., (2002). Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys. Acta. 1570:27–32.
72. Schurgers, L., Cranenburg, E., and Vermeer, C., (2008). Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb Haemost. 100:593–603.
73. Schurgers, L., Teunissen, K., Hamulyák, K., Knapen, M., Vik, H., and Vermeer, C., (2007). Vitamin K-containing dietary supplements: Comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 109:3279–3283.
74. Schurgers, L., Barreto, D., Barreto, F., Liabeuf, S., Renard, C., Magdeleyns, E., Vermeer, C., Choukroun, G., and Massy, Z., (2010). The circulating inactive form of Matrix Gla Protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin. J. Am. Soc. Nephrol. 5:568–575.
75. Schurgers, L., Dissel, P., Spronk, H., Soute, B., Dhore, C., Cleutjens, J., and Vermeer, C., (2001). Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol. 90:57–63.
76. Schurgers, L., Shearer, M., Hamulyák, K., Stöcklin, E., and Vermeer, C., (2004). Effect of vitamin K intake on the stability of oral anticoagulant treatment: Dose-response relationships in healthy subjects. Blood. 104:2682–2689.
77. Schurgers, L., Spronk, H., Soute, B., Schiffers, P., DeMey, J., and Vermeer, C., (2007). Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood. 109:2823–2831.
78. Shea, M., and Holden, R., (2012). Vitamin K status and vascular calcification: Evidence from observational and clinical studies. Adv. Nutr. 3:158–165.
79. Shearer, M., (1996). Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J. Nutr. 126:1181–1186.
80. Shearer, M., and Newman, P., (2008). Metabolism and cell biology of vitamin K. Thromb Haemost. 100:530–547.
81. Shiraki, M., and Itabashi, A., (2009). Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: A randomized prospective study. J. Bone Miner Metab. 27:333–340.
82. Shiraki, M., Shiraki, Y., Aoki, C., and Miura, M., (2000). Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J. Bone Miner Res. 15:515–521.
83. Son, B., Kozaki, K., Iijima, K., Eto, M., Kojima, T., Ota, H., Senda, Y., Maemura, K., Nakano, T., Akishita, M., and Ouchi, Y., (2006). Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring gas6-Axl survival pathway. Circ Res. 98:1024–1031.
84. Spronk, H., Soute, B., Schurgers, L., Cleutjens, J., Thijssen, H., De Mey, J., and Vermeer, C., (2001). Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem. Biophys. Res. Commun. 289:485–490.
85. Spronk, H., Soute, B., Schurgers, L., Thijssen, H., De Mey, J., and Vermeer, C., (2003). Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J. Vasc Res. 40:531–537.
86. Steitz, S., Speer, M., Curinga, G., Yang, H., Haynes, P., Aebersold, R., Schinke, T., Karsenty, G., and Giachelli, C., (2001). Smooth muscle cell phenotypic transition associated with calcification. Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 89:1147–1154.
87. Takeuchi, Y., Suzawa, M., Fukumoto, S., and Fujita, T., (2000). Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone. 27:769–776.
88. Tankó, L., Christiansen, C., Cox, D., Geiger, M., McNabb, M., and Cummings, S., (2005). Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J. Bone Miner Res. 20:1912–1920.
89. Theuwissen, E., Smit, E., and Vermeer, C., (2012). The role of vitamin K in soft-tissue calcification. Adv. Nutr. 3:166–173.
90. Trumbo, P., Yates, A., Schlicker, S., and Poos, M., (2001). Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. J. Am. Diet Assoc. 101:294–301.
91. Urayama, S., Kawakami, A., Nakashima, T., Tsuboi, M., Yamasaki, S., Hida, A., Ichinose, Y., Nakamura, H., Ejima, E., Aoyagi, T., Nakamura, T., Migita, K., Kawabe, Y., and Eguchi, K., (2000). Effect of vitamin K2 on osteoblast apoptosis: Vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine. J. Lab Clin. Med. 136:181–193.
92. van den Heuvel, E., van Schoor, N., Lips, P., Magdeleyns, E., Deeg, D., Vermeer, C., and den Heijer, M., (2014). Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. Maturitas. 77:137–141.
93. Viegas, C., Cavaco, S., Neves, P., Ferreira, A., João, A., Williamson, M., Price, P., Cancela, M., and Simes, D., (2009). Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications. Am. J. Pathol. 175:2288–2298.
94. Viegas, C., Simes, D., Laizé, V., Williamson, M., Price, P., and Cancela, M., (2008). Gla-rich protein (GRP), a new vitamin K-dependent protein identified from Sturgeon cartilage and highly conserved. J. Biol. Chem. 283:36655–36664.
95. Wallin, R., Schurgers, L., and Wajih, N., (2008). Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb Res. 122:411–417.
96. Weijs, B., Blaauw, Y., Rennenberg, R., Schurgers, L., Timmermans, C., Pison, L., Nieuwlaat, R., Hofstra, L., Kroon, A., Wildberger, J., and Crijns, H., (2011). Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur. Heart J. 32:2555–2562.
97. Westenfeld, R., Krueger, T., Schlieper, G., Cranenburg, E., Magdeleyns, E., Heidenreich, S., Holzmann, S., Vermeer, C., Jahnen-Dechent, W., Ketteler, M., Floege, J., and Schurgers, L., (2012). Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am. J. Kidney Dis. 59:186–195.
98. Wong, S., Kwok, T., Woo, J., Lynn, H., Griffith, J., Leung, J., Tang, Y., and Leung, P., (2005). Bone mineral density and the risk of peripheral arterial disease in men and women: Results from Mr. and Ms Os, Hong Kong. Osteoporos Int. 16:1933–1938.
99. Yao, Y., Bennett, B., Wang, X., Rosenfeld, M., Giachelli, C., Lusis, A., and Boström, K., (2010). Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res. 107:485–494.